Translation of "Motivateur en matière de santé " (French → English) :

health influencer

reproductive health commodity | RH commodity

Community Action Programme on Health Promotion | Community action programme on health promotion, information, education and training | programme of Community action on health promotion, information, education and training

G-7 Global Healthcare Applications Project and the Information Society | Global Healthcare Applications Project | GHAP [Abbr.]

coverage of health and safety regulations | scope of health and safety regulations | coverage of health and safety standards | health and safety regulations

adjust project needs with concerns for health and safety | balance concerns of health and safety with project requirements | adapt project requirements with health and safety measures | balance the project requirements with health and safety concerns

contribute to practice innovations in health care | contribute to practice-innovation in health-care | adapt to new technological improvements in health care | contribute to practice innovation in health care

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include sel ...[+++]f-report data, analysis of blood and other body fluids, characteristic physical and psychological symptoms, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

health, safety and environment personnel [ health, safety and environmental personnel | HSE personnel | HSE-personnel ]

S & T at Work for the Health of Canadians: The Science and Technology Action Plan of the Federal Health Portfolio [ S & T at Work for the Health of Canadians | The Science and Technology Action Plan of the Federal Health Portfolio: S & T at Work for the Health of Canadians ]

20. Welcomes efforts to improve the quality of the regulatory framework and expects further progress in this field; reminds the Commission, however, that the submission of OSH directives to REFIT and modifications of the legislation should be democratic and transparent, involve social partners and should under no circumstances result in reductions in occupational health and safety; underlines, in this context, that changes in the workplace resulting from technological development should be taken into account; points out that Member States are free to adopt higher standards than the minimum OSH requirements; believes, nevertheless, th ...[+++]at the existing rules should be improved, inter alia, by avoiding overlapping and promoting better integration of OSH with other policy areas, while preserving and aiming at further raising of the level of health and safety protection of employees;

O. whereas precarious employment has adverse effects on occupational health and safety and is undermining existing occupational health and safety structures; whereas precarious employment may exclude workers from training and access to OSH services and is associated with mental stress due to job insecurity ; whereas the Framework Directive 89/391/EEC places the responsibility on employers to establish a systematic prevention policy covering all risks; whereas outsourcing of work through subcontracting and temporary agency work may make it more difficult to identify who is responsible for OSH provisions; whereas undeclared work and b ...[+++]ogus self-employment constitute a serious challenge to the implementation of OSH measures and workers’ health and safety;

Promote the voluntary uptake of health innovation and e-Health by increasing the interoperability of patient registries and other e-Health solutions; support cooperation on e-Health in the Union, in particular on registries, and its uptake by health professionals.

Specific activities shall include: understanding the determinants of health (including nutrition, physical activity and gender, and environmental, socio-economic, occupational and climate-related factors); improving health promotion and disease prevention; understanding disease and improving diagnosis and prognosis; developing effective prevention and screening programmes and improving the assessment of disease susceptibility; improving the surveillance of infectious diseases and preparedness for combating epidemics and emerging diseases; developing new and better preventive and therapeutic vaccines and drugs; using in-silico medicine for improving disease management and prediction; developing regenerative medicine and adapted treatm ...[+++]ents, and treating disease, including palliative medicine; transferring knowledge to clinical practice and scalable innovation actions; improving health information and better collection and use of health cohort and administrative data; standardised data analysis and techniques; active ageing, and independent and assisted living; individual awareness and empowerment for self-management of health; promotion of integrated care, including psychosocial aspects; improving scientific tools and methods to support policy making and regulatory needs; optimising the efficiency and effectiveness of healthcare provision; and reducing health disparities and inequalities by evidence-based decision making and dissemination of best practice and by innovative technologies and approaches.